Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021

SELL
$1.68 - $2.88 $10,080 - $17,280
-6,000 Closed
0 $0
Q2 2021

Jul 14, 2021

SELL
$1.88 - $3.56 $20,680 - $39,160
-11,000 Reduced 64.71%
6,000 $16,000
Q1 2021

Apr 12, 2021

BUY
$1.47 - $3.29 $24,990 - $55,930
17,000 New
17,000 $38,000
Q2 2020

Jul 10, 2020

SELL
$1.69 - $2.79 $33,800 - $55,800
-20,000 Closed
0 $0
Q1 2020

Apr 09, 2020

SELL
$1.59 - $3.35 $24,366 - $51,338
-15,325 Reduced 43.38%
20,000 $38,000
Q4 2019

Jan 10, 2020

BUY
$2.68 - $4.85 $8,755 - $15,844
3,267 Added 10.19%
35,325 $101,000
Q3 2019

Oct 25, 2019

BUY
$4.1 - $9.0 $29,417 - $64,575
7,175 Added 28.83%
32,058 $163,000
Q2 2019

Jul 24, 2019

SELL
$5.15 - $7.92 $39,124 - $60,168
-7,597 Reduced 23.39%
24,883 $197,000
Q1 2019

Apr 17, 2019

BUY
$5.1 - $6.71 $124,062 - $163,227
24,326 Added 298.33%
32,480 $214,000
Q4 2018

Jan 22, 2019

BUY
$4.2 - $9.74 $19,282 - $44,716
4,591 Added 128.85%
8,154 $45,000
Q3 2018

Oct 29, 2018

BUY
$6.72 - $10.4 $23,943 - $37,055
3,563 New
3,563 $32,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $278M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.